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Notch signaling inhibits differentiation of endocrine cells in the pancreas and intestine. In a number of
cases, the observed inhibition occurred with Notch activation in multipotential cells, prior to the
initiation of endocrine differentiation. It has not been established how direct activation of Notch in
endocrine precursor cells affects their subsequent cell fate. Using conditional activation of Notch in
cells expressing Neurogenin3 or NeuroD1, we examined the effects of Notch in both organs, on cell fate
of early endocrine precursors and maturing endocrine-restricted cells, respectively. Notch did not
preclude the differentiation of a limited number of endocrine cells in either organ when activated in
Ngn3þ precursor cells. In addition, in the pancreas most Ngn3þ cells adopted a duct but not acinar cell
fate; whereas in intestinal Ngn3þ cells, Notch favored enterocyte and goblet cell fates, while selecting
against endocrine and Paneth cell differentiation. A small fraction of NeuroD1þ cells in the pancreas
retain plasticity to respond to Notch, giving rise to intraislet ductules as well as cells with no detectable
pancreatic lineage markers that appear to have limited ultrastructural features of both endocrine and
duct cells. These results suggest that Notch directly regulates cell fate decisions in multipotential early
endocrine precursor cells. Some maturing endocrine-restricted NeuroD1þ cells in the pancreas switch
to the duct lineage in response to Notch, indicating previously unappreciated plasticity at such a late
stage of endocrine differentiation.
& 2012 Elsevier Inc. All rights reserved.Introduction
Endocrine cells in the pancreas and intestine differentiate from
multipotential epithelial cells derived from the early gut endoderm. In
the pancreas, relatively undifferentiated epithelial cells give rise to the
duct, acinar, and endocrine lineages prior to birth. At least ﬁve
different endocrine cell types form the islets of Langerhans including
insulin producing b cells, as well as a, q, PP, and e cells that produce
glucagon, somatostatin, PP, and ghrelin (Habener et al., 2005; Oliver-
Krasinski and Stoffers, 2008). In contrast, enteroendocrine cells that
express one or more of 12 hormones continuously differentiate from
precursors throughout postnatal life.
Endocrine differentiation in both the pancreas and intestine is
regulated by the temporal expression of basic helix loop helixll rights reserved.
B. Leiter).
.(bHLH) transcription factors to sequentially restrict subsequent
differentiation to speciﬁc lineages. Expression of the bHLH tran-
scription factor, Neurogenin 3 (Ngn3) initiates endocrine differ-
entiation following speciﬁcation of the pancreatic epithelium
by the homeodomain protein, Pdx1 early in pancreagenesis
(Gu et al., 2002).
The absence of pancreatic endocrine cells in Ngn3/ mice
suggests that Ngn3 is required for their speciﬁcation (Gradwohl
et al., 2000). Lineage analysis of the descendants of Ngn3þ cells
showed that all endocrine cells in the pancreas arose from Ngn3þ
cells, indicating that the effects of Ngn3 were cell autonomous.
However, lineage tracing also revealed that small numbers of acinar
and duct cells arose from Ngn3 expressing cells, suggesting that
Ngn3þ cells were not restricted to an endocrine cell fate (Gu et al.,
2003; Schonhoff et al., 2004).
NeuroD1, another bHLH protein, was initially described as an
activator of the insulin gene (Naya et al., 1995). NeuroD1 knock-
out mice develop severe diabetes with reduced numbers of b cells
(Naya et al., 1997). The absence of NeuroD1 in Ngn3 null mice
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2000). Ngn3 and the homeodomain protein, NKX2.2, (Anderson
et al., 2009; Huang et al., 2000) directly activate NeuroD1
transcription, suggesting that NeuroD1 is expressed at a later
stage of islet differentiation.
In the intestine, the three secretory lineages, enteroendocrine,
Paneth, and goblet cells require the bHLH protein, Atoh1 for
differentiation (Shroyer et al., 2005; Yang et al., 2001). Presum-
ably, Ngn3 initiates endocrine differentiation as enteroendocrine
precursor cells segregate from a common secretory progenitor
cell. As in the pancreas, intestinal enteroendocrine cells are
absent from Ngn3 null mice although some endocrine cells in
the stomach differentiate in the absence of Ngn3 expression
(Jenny et al., 2002; Lee et al., 2002). Much like the pancreas,
Ngn3 expressing cells in the intestine are multipotential, con-
tributing to the goblet and Paneth cell lineages (Schonhoff et al.,
2004). Secretin and cholecystokinin cells fail to develop in neuroD1
null mice whereas other enteroendocrine cell types are present (Naya
et al., 1997). NeuroD1 is expressed in nearly all enteroendocrine cell
types where it may have a role in inhibiting cell proliferation as cells
mature (Mutoh et al., 1998; Ratineau et al., 2002).
A number of studies suggest that Notch signaling inhibits
endocrine differentiation in both the pancreas and the intestine.
Many of the effects of Notch result from its inhibition of bHLH
proteins that activate cellular differentiation programs. Thus
Ngn3 and NeuroD1 are potential targets of Notch in the pancreas
and the intestine. Notch signaling increases expression of its
transcriptional effector protein, Hes1, in the pancreas (Jarriault
et al., 1998), inhibiting expression and/or transcriptional activity
of bHLH proteins (Davis and Turner, 2001). The Ngn3 gene has
multiple Hes1 binding sites and is repressed by Hes1, suggesting
it may be a target of Notch (Lee et al., 2001).
Activation of Notch at a relatively early stage of pancreatic
development in cells expressing Pdx1 resulted in failure to
develop both endocrine and acinar cells with the remaining
pancreatic cells trapped in a relatively undifferentiated state
(Hald et al., 2003; Murtaugh et al., 2003). Likewise, activation of
Notch in cells expressing either villin or fatty acid binding protein
showed a signiﬁcant reduction in enteroendocrine and goblet cells
(Fre et al., 2005; Stanger et al., 2005). The timing and context of
Notch activation is a major determinant of its effects on organogen-
esis and differentiation. The studies described above involved the
effects of Notch activation in broad populations of multipotential
cells in each organ that give rise to several cell lineages in addition to
endocrine cells. The observed effects of Notch in these studies were
likely the result of its activation prior to the initiation of endocrine
differentiation. The inhibitory role of Notch was further suggested by
excessive endocrine differentiation seen with widespread disruption
of Notch function in the pancreas (Apelqvist et al., 1999; Jensen et al.,
2000) and in the fetal intestine (Jensen et al., 2000).
The effects of Notch activation in endocrine precursor cells in
the pancreas have been examined in limited detail. The results
were interpreted to suggest complete inhibition of endocrine
differentiation in early endocrine precursors with less pro-
nounced effects in maturing islet cells (Greenwood et al., 2007;
Murtaugh et al., 2003). The effects of Notch activation in enter-
oendocrine precursor cells have not been described.
In the present study, we have examined the effect of con-
ditionally activating Notch signaling in early and late endocrine
precursor cells expressing Ngn3 or NeuroD1, respectively in the
pancreas and intestine. Unexpectedly, activation of Notch in
Ngn3þ cells did not prevent the initiation of endocrine differ-
entiation in the pancreas or the intestine. However a number of
islet cell types failed to mature in the pancreas. Many cells
switched to a duct cell fate in pancreas and enterocyte and goblet
cell fate in intestine. Surprisingly, some NeuroD1þ cells in thepancreas respond to Notch and differentiate into duct cells,
whereas maturing enteroendocrine precursors were relatively
unaffected by Notch.Material and methods
Animals
Sequences encoding Cre recombinase that included a nuclear
localization signal and simian virus 40 polyadenylation sequences
were introduced into a murine BAC clone, RPCI-23188B11 (Invi-
trogen) containing the NeuroD1 locus, by homologous recombi-
nation in E. Coli with a linear DNA fragment ampliﬁed from the
suicide vector pKD4 as described previously (Cotta-De-Almeida
et al., 2003; Datsenko and Wanner, 2000; Schonhoff et al., 2004).
The Cre encoding sequences were inserted into the translation
initiation ATG of the NeuroD gene. A Ngn3-CreERT2 transgene was
generated by inserting CreERT2 sequences into the same Ngn3
BAC described previously (Schonhoff et al., 2004).
Transgenic mice were generated by pronuclear injection of the
puriﬁed circular NeuroD1-Cre BAC or Ngn3-CreERT2 BAC DNA into the
pronuclei of fertilized oocytes of B6XB6D2F1 mice. Founders were
generated and were identiﬁed by genotyping with primers speciﬁc
for the Cre transgene. We generated 2 NeuroD1-Cre and 3 Ngn3-
CreERT2 pedigrees. For each line, the pedigrees showed nearly
identical pattern of Cre expression. The Ngn3-Cre mice have been
described earlier (Schonhoff et al., 2004). The PCR primers used for
generating BAC NeuroD1-Cre transgene were: Sense- TGCTTGCCTCTC-
TCCCTGTTCAATACAGGAAGTGGAAACATGCCCAAGAAGA AGAGGAA
and antisense-GGCTCGCCCATCAGCCCGCTCTCGCTGTATGATTTGGT-
CATCCTCCTTAGTTCCTATTCCGA.
For lineage tracing experiments, NeuroD1-Cre transgenic mice
were crossed with ROSA26-LacZ (B6.129-Gt26Sortm) or ROSA26-EYFP
(B6.1291-Gt (ROSA) 26Sortm1(EYFP) Cos) indicator mice (Soriano,
1999). To determine if Ngn3 and NeuroD1 expressing cells are
susceptible to Notch, Ngn3-Cre (Schonhoff et al., 2004), NeuroD1-Cre
and Ngn3-creERT2mice were crossed with ROSA26 Notch/Notch knock-
in mice that contain the intracellular domain of murine Notch1 and
a bicistronic nuclear EGFP reporter downstream of a ﬂoxed stop
sequence (Murtaugh et al., 2003). Cre activity was induced in Ngn3-
creERT2;ROSANotch/þ mice by treating 6 weeks old mice with 2 mg
tamoxifen (Sigma, T5648) dissolved in corn oil with one intraper-
itoneal injection per day for 5 days. Tissues were harvested and
analyzed 7 day later. The Institutional Animal Care and Use
Committee approved all vertebrate animal studies in accordance
with NIH regulations.
Immunohistochemistry
Tissues for X-Gal staining were performed as previously described
(Schonhoff et al., 2004). Fixed tissue samples were processed for
either frozen or parafﬁn sections using standard methods.
The following primary antibodies were used for immunohis-
tochemical and immunoﬂuorescence analysis: Goat anti-NeuroD1
(1:500, Santa Cruz), Goat anti-EGFP (1:100, Abcam), Rabbit anti-
GFP (1:10,000, Invitrogen), Guinea pig anti-Insulin (1: 5000, Sorin
Biomedica), Guinea pig anti-PYY (1: 5000, a gift from G. Aponte,
University of California, Berkley), Rabbit anti-ChromograninA
(1:1000, Immunostar), Rabbit anti-Somatostatin (1:8000, a gift
from R. Lechan, Tufts Medical Center), Rabbit anti-Glucagon (1:
3000, a gift from M. Appel, University of Massachusetts), Rabbit
anti-Pancreatic Polypeptide (1: 5000, a gift from Chance, Eli Lilly),
Rabbit anti-b-Gal (1:600, Cappel), Wisteria Fluoribunda Aggluti-
nin (WFA, 1: 600, Sigma), Biotinylated Dolichos Biﬂorus Aggluti-
nin (DBA, 1:1000, Vector Laboratories), Mouse anti-Neurogenin3
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Developmental Studies Hybridoma Bank), Rabbit anti-Pdx1
(1:5000, Invitrogen), Rabbit anti-Muc2 antibody (1:400, a gift
from Dr. S. Krasinski, Harvard Medical School), Rabbit anti-LPH
(1:1000, K. Yeh, Louisiana State University), Rabbit anti-Secretin
(1:400, a gift from Dr. W. Chey, University of Rochester), Rabbit
anti-CCK (1:1000, a gift from Dr. W. Chey, University of Roche-
ster). Intestinal epithelial Alkaline Phosphatase activity was
detected using an Alkaline Phosphatase Substrate Kit (Vector Lab.)
For immunoﬂuorescence analysis, Alexa Fluor 488 or 594
conjugated secondary antibodies were used at a dilution of
1:800. Tyramide Signal Ampliﬁcation (TSA) kit (Molecular probes)
was used for co-localization studies with two primary antibodies
raised in the same species (Brouns et al., 2002). For immunohis-
tochemical analysis, biotin conjugated secondary antibodies were
used at a dilution of 1: 400 (Jackson ImmunoResearch) and were
ampliﬁed with Vectastain ABC and DAB kits (Vector Laboratories)
using standard protocols. Images were obtained with Nikon
Eclipse E600 microscope. For morphometric analyses of cells
expressing EYFP or EGFP, multiple sections separated by at least
25 m from at least 3 mice were examined for each genotype.Fig. 1. Notch activation in Ngn3þ early pancreatic endocrine progenitors limits
ROSANotch/þ mice (A) or Ngn3-Cre;ROSANotch/þ mice (B)–(D) stained for Glucagon (Gluc
cytoplasmic CGA (B) and PYY (C) expression in cells expressing nuclear EGFP at hi
(E) Representative islet sections from two-month old Ngn3-CreERT2-ROSAEYFP (E) o
immunostaining colocalized with cytoplasmic EYFP (E), and with nuclear EGFP expressi
(B) 16 mm; (C) 10 mm; (D) 32 mm; (F) 9 mm. (For interpretation of the references to coResults were normalized to the total area of pancreatic or islet
tissue on the slides examined. Type II two-tailed or type III one-
tailed Student t-test was used to analyze grouped data sets.
Po0.05 was considered signiﬁcant. Confocal images were
obtained with a Zeiss LSM 510 Meta microscope. Digital decon-
volution was performed on confocal images to conﬁrm colocali-
zation of multiple ﬂuorescent labels in the same cell in multiple
focal planes using the EPR program that was developed by the
imaging group at the University of Massachusetts Medical School.
Electron microscopy
Pancreata from adult transgenic and age-matched control mice
were ﬁxed in 2.5% glutaraldehyde or in a mixture of 2.5%
glutaraldehyde and 2% paraformaldehyde solution in 0.1 M caco-
dylate buffer pH 7.4. Part of the samples was post-ﬁxed in 1%
osmium tetroxide in 0.1 M phosphate buffer, pH 7.4 and
embedded in Epon-Araldite. Areas of interest were trimmed,
sectioned with a LKB Type 8802 ultramicrotome (60–100 nm),
collected on uncoated nickel 200–300 mesh grids, desiccated,
counterstained with uranyl acetate and Reynold’s lead citratebut does not preclude endocrine differentiation. Pancreatic sections from P1
), Insulin (Ins), EGFP (GFP), Chromogranin A (CGA, and PYY. Insets (B)–(C) show
gher magniﬁcation. Inset D shows co-expression of PYY and Glucagon (arrow).
r Ngn3-CreERT2-ROSANotch/þ (F) mice treated with Tamoxifen showing insulin
on (F). Nuclei were counter-stained with DAPI (blue). Scale bar: (A) and (E), 20 mm;
lor in this ﬁgure legend, the reader is referred to the web version of this article.)
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scope (Philips, The Netherlands). Indirect immunogold labeling
studies for GFP were performed on osmiﬁed samples with the
rabbit polyclonal serum (1:100, Invitrogen, USA), using 10 nm
gold-labeled anti rabbit immunoglobulins (BB International, UK)
as described (Rindi et al., 2002).Fig. 2. Notch activation in Ngn3þ endocrine progenitors induces cell-fate
switching to the duct lineage during development. (A)–(C) A representative
pancreatic section from a 2-day old Ngn3-Cre; ROSAEYFP mouse triple stained for
EYFP (A, brown), DBA (B, red) and CGA A (B, green). Yellow and black arrowheads in
(A) and (C) denote single and pairs of duct cells expressing EYFP. (D)–(F) Pancreatic
sections from 2-day old Ngn3-Cre; ROSANotch/þ mice stained for EGFP, DBA, CGA or
Glucagon. (D) Many EGFP expressing cells in the pancreas stain for DBA (arrows,
inset). Occasional DBA stained cells did not express EGFP, red arrowheads. (E)–(F)
Chromogranin A and Glucagon (white arrows) are not expressed in DBAþ cells (red
arrows). G. Bar graph shows the total number of EYFP cells or EGFP cells (blue bars)
and the total coexpressing chromogranin A (CGA, red bars) or DBA (green bars).
Results are the average from pancreatic sections from 2 day old Ngn3-Cre; ROSAEYFP
or Ngn3-Cre; ROSANotch/þ mice. Multiple sections from each of three mice for each
genotype were examined and the results were normalized for pancreatic area and
expressed as the mean7sd. The average areas in the pancreas of each mouse line
surveyed were 425,866 mM2 for Ngn3-Cre; ROSAEYFP mice and 593,727 mM2 for
Ngn3-Cre; ROSANotch/þ mice. p-values were determined using a type II two-tailed
Student t-test: *po0.064; **po0.000025; ***po0.0008. Scale bar: (A)–(C) 30 mm;
(D) 32 mm; (E) and (F) 9 mm. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)Results
Notch activation in Ngn3-expressing endocrine precursors in the
pancreas limits endocrine differentiation with switching to the duct
lineage
To assess the effect of Notch signaling in early endocrine
progenitor cells of the pancreas, we conditionally activated Notch
signaling in Ngn3þ cells by crossing ROSANotch/Notch mice
(Murtaugh et al., 2003) with mice expressing Cre recombinase
under control of a BAC containing the Ngn3 locus (Schonhoff
et al., 2004). Excision of stop sequences by Cre enabled expression
of the intracellular domain of Notch1 (NICD) as well as EGFP,
which facilitated identiﬁcation of cells expressing NICD.
Ngn3-Cre;ROSANotch/þ mice were born at the expected Mendelian
frequency and were indistinguishable from their wild type
littermates at birth. Thereafter, Ngn3-Cre;ROSANotch/þ mice lost
weight, became hyperglycemic, and died by postnatal day 3.
Islets failed to develop in pancreata of Ngn3-Cre;ROSANotch/þ
mice, unlike control ROSANotch/þ mice (Fig. 1A and B). However we
frequently observed individual chromogranin A (CGA) stained
cells that expressed EGFP, indicating that Notch signaling in
Ngn3þ cells did not preclude endocrine differentiation (Fig. 1B)
as previously suggested (Murtaugh et al., 2003). Further char-
acterization of the EGFPþ endocrine cells revealed that peptide YY
(PYY) was the most frequently expressed hormone (Fig. 1C). A
smaller number of cells expressed glucagon, with some coexpres-
sing PYY (Fig. 1D, arrow in the inset points to one cell coexpres-
sing PYY/Glucagon). However, we were unable to identify insulin-,
somatostatin- or PP-expressing cells.
The neonatal lethality of Ngn3-Cre;ROSANotch/þ mice limited
our studies to two-day-old mice. In order to examine the effects
of Notch activation in early endocrine precursor cells of adult
mice, we generated transgenic mice that expressed a tamoxifen
inducible Cre (CreERT2) under control of the same Ngn3 BAC used
for the Ngn3-Cre transgene. Following Tamoxifen induction in 8
week-old mice, we observed approximately 0–4 cells that
expressed EYFP or EGFP per islet from both Ngn3-CreERT2;RO-
SAEYFP and Ngn3-CreERT2;ROSANotch/þ mice, respectively (Fig. 1E
and F). Morphometric analysis indicated that the frequency
of labeling was not statistically different with Notch activation
(p¼0.43, type II, 2-tailed Student t-test). The relatively low
frequency of labeling most likely is the result of the very small
number of Ngn3þ cells normally present in the adult pancreas as
well as the mosaic recombination characteristic of inducible Cre
enzymes. Approximately 90% of Ngn3þ cells in adult mice
differentiate into insulin-expressing cells (Fig. 1E and F) with
nearly all staining for chromogranin A (not shown) in both Ngn3-
CreERT2;ROSAEYFP and Ngn3-CreERT2;ROSANotch/þ mice. In con-
trast to the reduced endocrine differentiation in fetal pancreas
described above with the noninducible Cre, our observations
suggest that Ngn3þ cells in adult mice are no longer responsive
to Notch.
Ngn3þ cells give rise to occasional duct cells appearing as
individual or pairs of cells in the normal neonatal pancreas
(Fig. 2A–C). In contrast, the majority of EGFPþ cells in neonatal
Ngn3-Cre;ROSANotch/þ mice stained for dolichos biﬂorus agglutinin
(DBA), a lectin expressed on pancreatic duct cells (Fig. 2D).
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with Notch activation. EGFP-expressing cells also stained for
Wisteria Floribunda Agglutinin (WFA) and Cytokeratin 19, further
identifying them as duct cells (Suppl. Fig. S1, top panel). In many
cases, endocrine cells were in close proximity to duct cells but we
were unable to identify any cells expressing both duct and
endocrine markers (Fig. 2E and F). The absence of hormone
colocalizing with duct lineage markers suggested that many
Ngn3þ cells switched to the duct lineage as a result of Notch
activation.
The increased frequency of duct cells arising from Ngn3þ cells
following Notch activation was far greater than what we pre-
viously described in Ngn3-Cre;ROSA26 mice (Schonhoff et al.,
2004). To determine whether the apparent increase in duct cells
represented an increase in the absolute number versus a relativeFig. 3. NeuroD1 expression occurs in endocrine-restricted precursors. (A) Structu
glucagon, somatostatin, and PP (E) in descendants of NeuroD expressing cells in the
confocal images in multiple planes by deconvolution analysis. Arrows indicate doubl
(C) Left panel: b-Galactosidase activity (blue) is restricted to islets of adult NeuroD1-Cre
stained for b-gal activity (blue) and WFA (brown). Tubular WFAþ cells are distinct fro
Endocrine cells (e), Duct cells (d). Right panel: e15.5 pancreas of NeuroD1-Cre; RosaEYFP
left panel, 80 mm; middle and right panels, 20 mm; (B) and (E) 10 mm; (D) 8 mm. (For int
the web version of this article.)increase resulting from the loss of endocrine cells we com-
pared the number of duct cells (standardized per unit area)
arising from normal Ngn3þ cells in Ngn3-Cre;ROSAEYFP mice to
those arising from Ngn3þ cells in Ngn3-Cre;ROSANotch/þ mice. We
found that 9.1% of EYFPþ cells in 2-day-old Ngn3-Cre;ROSAEYFP
mice stained for DBA. The total number of cells arising from
Ngn3þ cells in Ngn3-Cre;ROSANotch/þ mice was comparable to
Ngn3-Cre;ROSAEYFP mice (Fig. 2G, p40.064). With Notch activa-
tion, we observed a large increase in the fraction that was fated to
the duct lineage (Fig. 2 G. po0.00003), suggesting that Notch led
to an absolute reduction in endocrine cells with a corresponding
increase in the number of duct cells. The duct cells identiﬁed in
Ngn3-Cre;ROSANotch/þ mice only occasionally stained for cell
proliferation markers (not shown), suggesting that they did not
arise from expansion of an otherwise minor cell population.re of NeuroD-Cre transgene. (B) (D)–(E) Expression of NeuroD (B); insulin (D);
pancreas of adult NeuroD1-Cre; ROSA26R mice. Colocalization was conﬁrmed in
e positive cells. Representative double positive cells are magniﬁed in the insets.
; ROSA26R mice. Middle panel: Pancreas from e16.5 NeuroD1-Cre; ROSA26R mouse
m those expressing b-gal and do not arise from NeuroD1þ cells. Acinar cells (a),
mouse showing all EYFPþ cells stained for Chromogranin A (arrows). Scale bar: (C)
erpretation of the references to color in this ﬁgure legend, the reader is referred to
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acinar cells in adult mice arose from Ngn3þ cells (Schonhoff
et al., 2004), we were unable to identify acinar cells arising from
Notch activation in Ngn3þ cells, consistent with Notch inhibition
of acinar differentiation (Kopinke et al., 2012).
NeuroD1þcells are restricted to an endocrine cell fate in the
pancreas
To determine whether cells expressing NeuroD1, a downstream
target of Ngn3, retain the capacity to respond to Notch, we
generated transgenic mice that express Cre recombinase under
control of the NeuroD1 gene in order to activate Notch in NeuroD1þ
cells. Cre was inserted at the translational initiation site of a
NeuroD1 bacterial artiﬁcial chromosome (BAC) containing 118 kB
of 50 and 82 kB of 30 ﬂanking sequence (Cotta-De-Almeida et al.,
2003; Datsenko and Wanner, 2000; Yu et al., 2000) (Fig. 3A).
We initially crossed NeuroD1-Cre mice to ROSA26-LacZ (R26R)
indicator mice to identify all cells that arose from NeuroD1þ cells
by recombination based cell lineage analysis (Soriano, 1999;
Zambrowicz et al., 1997). Cre expression appeared to be identical
for each of two independent pedigrees with expression of
b-galactosidase in all NeuroD1þ cells in the pancreas, indicating
that Cre expression was restricted to the appropriate cells,
recapitulating the expression of the endogenous gene (Fig. 3B).
Staining for b-galactosidase activity was restricted to islets with
no staining seen in either duct or acinar cells (Fig. 3C, left panel).
Whereas Ngn3þ cells give rise to small numbers of non-endocrine
cells (Schonhoff et al., 2004), NeuroD1-expressing cells were
restricted to an endocrine cell fate.
Further analysis of NeuroD1-Cre;R26R mice revealed that all
insulin-expressing b cells stained for b-galactosidase, indicating that
they arose from NeuroD1 expressing cells (Fig. 3D). To determine
whether non-b cells arose from cells that expressed NeuroD1, we
stained sections for b-galactosidase either with glucagon, somatos-
tatin, or PP (Fig. 3E). In order to resolve the non-ß cells from
surrounding b cells in slightly offset focal planes, we combined
confocal microscopy with deconvolution analysis. Approximately
15% of non-ß endocrine cells stained for b-galactosidase, indicating
that most (95%) of NeuroD1þ cells are committed to a b-cell fate
as we suggested previously (Itkin-Ansari et al., 2005).
We examined NeuroD1-Cre;ROSAEYFP mice at e16.5 to determine
whether NeuroDþ cells in the fetal pancreas were multipotential.
EYFP expression was restricted to chromogranin A expressing
endocrine cells at e16.5 (Fig. 3C, right panel). Likewise, we were
unable to identify b-galactosidase activity in either duct or acinar
cells of NeuroD1-Cre;R26R mice (Fig. 3C, middle panel), indicating
that NeuroD1þ cells were endocrine restricted in both the fetal and
adult pancreas, unlike Ngn3þ cells that gave rise to increased
number of nonendocrine cells prior to birth (Cras-Meneur et al.,
2009; Magenheim et al., 2011; Schonhoff et al., 2004). These
observations suggest that expression of NeuroD1 represents a
distinct, later stage of endocrine differentiation where cells are
committed to an endocrine cell fate.
Notch activation in late endocrine restricted precursor cells in
pancreas islets.
We next examined the effect of Notch activation in NeuroD1þ
cells in the islets to determine whether cells at this later stage of
differentiation still respond to Notch signaling. In contrast to
Ngn3-Cre;ROSANotch/þ mice, NeuroD1-Cre;ROSANotch/þ mice were
healthy, and indistinguishable from their normal littermates.
Most islets of NeuroD1-Cre;ROSANotch/þ mice appeared histologi-
cally indistinguishable from islets in normal mice in contrast tothe absence of islet morphogenesis when Notch was activated at
an earlier stage of endocrine differentiation in Ngn3þ cells.
Unlike the uniform staining for insulin throughout the central
islet core of normal mice (Fig. 3D), some cells in the center of
islets in NeuroD1-Cre;ROSANotch/þ mice did not stain for insulin
(Fig. 4A). Instead we observed occasional cells that expressed
glucagon, somatostatin (Fig. 4B and C), and PP (not shown) in the
islet core rather than exclusively at the islet periphery as seen in
normal islets (Fig. 3E). This change in distribution of hormone
expression was present in most islets of mice ranging from 2 day
to over one year of age. Most insulin, glucagon, somatostatin, and
PP cells in the islet core expressed EGFP (Fig. 4A–C), suggesting
that Notch signaling does not prevent endocrine differentiation of
NeuroD1þ cells although it may inﬂuence the localization of
different cell types in the islet core. EGFP expressing cells in most
islets continued to express NeuroD (Fig. 4D–F), suggesting that
NeuroD may not be a direct target of Notch signaling in contrast
to Ngn3.
Overall there was little change in the total number of non-insulin
expressing endocrine cells. The Ki67 labeling index for glucagon-
expressing cells was not signiﬁcantly increased in NeuroD1-Cre;
ROSANotch/þ mice, suggesting that the effects of Notch activation did
not result from expansion of the a cell lineage. Glucagon expressing
cells in the islet center of NeuroD1-Cre;ROSANotch/þ mice did not
express MafA (not shown), a marker of mature ß cells (Nishimura
et al., 2006). None of the glucagon-, somatostatin-, or PP expressing
cells in the islet center coexpressed insulin, further suggesting that
they did not retain properties of mature b cells (Suppl. Fig. S2).
NeuroD1-Cre; ROSANotch/þ mice were normoglycemic with normal
glucose tolerance (not shown), suggesting that Notch activation
had little impact on b cell function and did not impair glucose
homeostasis.
Notch activation in differentiating islet cells induces cell fate
switching to duct cells
The effects of Notch activation on endocrine differentiation in
NeuroD1þ cells appeared to be relatively mild compared to the
absence of islet morphogenesis seen with Notch activation in early
endocrine precursor cells expressing Ngn3 (Fig. 1B). Whereas 90% of
islets in the pancreas of NeuroD1-Cre; ROSANotch/þ appeared normal,
we observed a group of EGFP-expressing cells in 10% islets that
did not express Chromogranin A (Fig. 4G, inset, arrows), suggesting
that Notch activation may alter the cell fate of NeuroD1þ cells
normally destined to become endocrine cells.
To determine if NeuroD1þ cells switched to alternate nonendo-
crine cell fates in response to Notch, we examined EGFP-expressing
cells for expression of markers for duct and acinar cells. Some of the
EGFPþ cells appeared to be individual duct cells or in small intraislet
ductules (Fig. 4G, H and L). With Notch activation, approximately 77
3% of EGFPþ cells expressed DBA, whereas we never identiﬁed DBA
expression in cells arising from NeuroD in NeuroD1-Cre;ROSA26 mice
(po0.02, type III, one-tailed Student t-test). Unlike EGFP-expressing
endocrine cells (Fig. 4D–F) these EGFP labeled duct cells no longer
expressed NeuroD1 (Fig. 4H), suggesting that Notch either directly or
indirectly suppressed NeuroD1 expression in cells that switched to a
duct cell fate. We were unable to detect Ngn3 in the adult pancreas of
NeuroD1-Cre; ROSANotch/þ or normal mice (Suppl. Fig. S3), consistent
with the difﬁculties encountered by others in detecting Ngn3
expression with available antibodies in the adult pancreas (Wang
et al., 2009). In addition, we were unable to identify amylase
expression in EGFPþ cells, suggesting that they did not switch to
the acinar lineage (Suppl. Fig. S4). We observed EGFP expressing cells
in approximately 10% of ducts of NeuroD1-Cre; ROSANotch/þ mice at all
ages from P2 to 41year. Some ducts were entirely comprised of
EGFPþ cells (Fig. 4G) whereas others contained one to several EGFPþ
Fig. 4. Activation of Notch in late islet precursors induces cell-fate switching to the duct lineage. (A)–(C) Islets from an adult NeuroD1-Cre; ROSANotch/þ mouse showing
nuclear EGFP expression with insulin (A), glucagon (B), and somatostatin (C) in the islet center. Insets (A)–(C) at higher magniﬁcation show cytoplasmic hormone
expression in cells expressing nuclear EGFP. (D)–(F) Pancreas of a 5-week-old NeuroD1-Cre; ROSANotch/þ mouse showing expression of NeuroD1 in cells with activated
Notch (EGFP). (G) Islet from an adult mouse stained for EGFP and chromogranin A. Inset shows EGFPþ cells with (arrowhead) and that do not express CGA (arrows). Circle
denotes small intraislet ductule, d. (H) Higher magniﬁcation of an intraislet ductule with several duct cells expressing EGFP (left panel), but not NeuroD1 (right panel).
(I) Adult pancreas from NeuroD1-Cre; ROSANotch/þ mice stained with a mixture of antibodies (Endo) against insulin, glucagon, somatostatin, PP, and PYY (red) and for EGFP
(green). EGFPþ cells form large cystic duct-like structures (arrow) and EGFPþ endocrine cells. (J)–(K) Large islet with intraislet ductules (red arrows) and an associated
large duct (red arrowhead) with brown staining for EGFP. (K) High magniﬁcation of (J); (L) Pancreas from NeuroD1-Cre; ROSANotch/þ mice showing a ductule with EGFPþ
cells coexpressing DBA (White arrowheads) as well as DBAþ/EGFP ductules (red arrowheads). Scale bar: (A)–(C), and (I), 60 mm; (D)–(F), 30 mm; (G)–(H), 10 mm; (J)
140 mm; (K) 20 mm; (L) 47 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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ciated with large dilated cystic structures lined with cuboidal EGFPþ
cells (Fig. 4 I) similar to structures reported previously with Notch
activation at very early stages of pancreagenesis in Pdx1þ cells (Hald
et al., 2003; Kopinke et al., 2011; Murtaugh et al., 2003). We also
identiﬁed large EGFP-expressing ducts associated with islets as well
as small intraislet ductules within a large adjacent islet (Fig. 4J and K).
We further characterized ducts arising from NeuroD1þ endo-
crine precursor cells in NeuroD1-Cre; ROSANotch/þ mice for expres-
sion of the homeodomain protein, Pdx1, which is expressed in
immature duct cells. Pdx1 expression in ducts decreases during
gestation and is not seen in mature ducts (Gu et al., 2002;
Wescott et al., 2009). In 2-day-old animals, Pdx1 expression
occurred mostly in developing islets (Suppl. Fig. S5). The absence
of Pdx1 in most duct cells following Notch activation suggests
that these cells are relatively mature, although we identiﬁed rarePdx1þ cells that stained for both EGFP and the duct marker, WFA
(Suppl. Fig. S5, arrow).
Identiﬁcation of novel cells in the pancreas with features of both
endocrine and ductal differentiation.
Our results suggest that a fraction of maturing endocrine cells
that express NeuroD1 retain the capacity to respond to Notch
signaling with resultant minor changes in the intraislet distribu-
tion of endocrine cells. Less frequently, NeuroD1þ cells switch to
an alternate duct cell fate but never become acinar cells (Suppl.
Fig. S4). To ensure we had identiﬁed all potential cell types that
arose from activation of Notch in NeuroDþ cells, we examined
EGFPþ cells in sections from NeuroD1-Cre; ROSANotch/þ mice for
both WFA, and chromogranin A expression (Fig. 5A). As antici-
pated, we identiﬁed EGFPþ cells that stained for the endocrine
Fig. 5. Loss of pancreatic lineage markers following Notch activation in
NeuroDþ cells. (A) Triple staining for chromogranin A, (red immunoﬂuorescence),
nuclear EGFP (Immunoperoxidase, brown), and WFA (blue). Higher magniﬁcation
views of the inset show separate staining of the same section for EGFP (B),
chromogranin A (C), and WFA (D). Large Arrows show two cells that coexpress both
EGFP and CGA. Small Arrows show cells expressing both WFA and EGFP. Arrow-
heads show three EGFPþ cells that do not stain for either WFA or CGA. Scale bar:
(A) 12 mm; (B)–(D), 6.0 mm. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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cells staining for the ductal marker, WFA (Fig. 5B–D, small arrows).
In addition we identiﬁed a subset of EGFPþ cells that did not
express either WFA or chromogranin A (Fig. 5B–D, arrowheads).
We examined pancreata of NeuroD1-Cre; ROSANotch/þ mice by
electron microscopy to further characterize other cell types
present. We identiﬁed a group of four cells in what appeared to
be an intraislet ductule. These cells had relatively featureless
cytoplasm and surrounded a lumen lined by microvilli and
occasional cilia, both characteristics of duct cells (Fig. 6A [a–c]).
The cells in this intraislet ductule also display desmosomes
(Fig. 6A–b), indicating their epithelial origin, and are clearly
distinguished from adjacent granule ﬁlled endocrine cells
(Fig.6A–a, right side). Unexpectedly, the lumen forming cells have
rare cytoplasmic electron dense granules with outer membranes
that are characteristic of endocrine secretory granules (Fig. 6A [b
and d] arrowheads).The cells described above that formed an intraislet ductule
represent a potentially novel cell type with features of both ductal
and endocrine differentiation. We identiﬁed two individual,
relatively featureless islet cells that appeared very similar to the
intraislet ductules just described and were surrounded by cells
ﬁlled with cytoplasmic electron dense secretory granules char-
acteristic of b cells. These cells had relatively clear cytoplasm
much like the intraislet duct cells and formed tight junctions with
neighboring cells, indicating that they were epithelial in origin
(Fig. 6B–a). Other features characteristic of duct cells included
two centrioles in one cell and a long microvillus in the other
(Fig. 6B–b). In the same two cells, we also identiﬁed rare
cytoplasmic electron dense granules with either coarse or punc-
tate cores, characteristic of endocrine secretory granules (Fig. 6B
[b–e]). Thus the clear cells also show features of both duct
(microvilli) and endocrine (secretory granules) differentiation in
a single cell and are ultrastructurally similar to the ductule cells
shown earlier (Fig. 6A). These appear to be relatively immature
cells with relatively limited structural features of duct and
endocrine cells. As a result these cells may not be sufﬁciently
differentiated to express markers of lineage speciﬁc differentia-
tion for ducts or endocrine cells using standard staining techni-
ques. Immunogold labeling for EGFP showed nuclear gold
particles over these clear cells, indicating that they were expres-
sing Notch-IC (Fig. 6B–f).
Notch activation in Ngn3þ cells limits intestinal endocrine
differentiation.
Ngn3 and NeuroD1 are also involved in the differentiation of
intestinal endocrine cells, suggesting that regulation of enteroen-
docrine cell fate may share common mechanisms with the
pancreas. We examined the fate of enteroendocrine precursors
cells following activation of Notch in either Ngn3-Cre;ROSANotch/þ
or NeuroD1-Cre;ROSANotch/þ mice. We identiﬁed many EGFPþ cells
in the neonatal small intestine of Ngn3-Cre;ROSANotch/þ mice
(Fig. 7B). However, EGFPþ cells only occasionally expressed
chromogranin A compared to Ngn3-Cre;ROSAEYFP mice, suggest-
ing that as in the pancreas, Notch limited but did not prevent
endocrine differentiation (Fig. 7A and B). EGFPþ cells appeared as
both individual cells as well as clusters of several columnar
epithelial cells (Fig. 7B). The neonatal lethality of Ngn3-Cre;ROSA-
Notch/þ mice limited our studies to two-day-old mice, prior to the
maturation of the enteroendocrine cell population in normal
mice. To examine the effects of Notch activation in early endo-
crine precursor cells of adult mice, we examined the cell fate of
intestinal Ngn3þ cells using the Ngn3-CreERT2 mice to condition-
ally activate Notch. As expected, we observed mosaic recombina-
tion in Tamoxifen treated mice, with a fraction of enteroendocrine
cells expressing EYFP when Ngn3-CreERT2 mice were crossed to
ROSAEYFP indicator mice (Suppl. Fig. S6).
Adult Ngn3-CreERT2; ROSANotch/þ mice treated with Tamoxifen
appeared healthy. With the exception of a single CGAþEGFPþ cell
(Fig. 7C, inset), we were unable to identify chromogranin A
expression in several hundred other EGFPþ cells. We observed
EGFP expressing cells in adult Ngn3-CreERT2;ROSANotch/þ mice as
individual cells or as groups of columnar cells. The columnar cell
clusters did not stain for Ki67, indicating that they were not an
actively expanding population (Fig. 7D).
Further examination of EGFPþ cells that did not express
chromogranin A in the intestine of Ngn3-Cre;ROSANotch/þ mice
showed intense apical border staining for lactase (LPH), a brush
border enzyme expressed at high levels in neonatal enterocytes
(Fig. 8A), suggesting that these endocrine precursors adopted an
enterocyte cell fate following Notch activation. In adult intestine
of tamoxifen treated Ngn3-creERT2; ROSANotch/þ mice, we further
Fig. 6. Ultrastructural identiﬁcation of primitive epithelial cells in islets with characteristics of both duct and endocrine cells in NeuroD1-Cre; ROSANotch/þ mice.
(A) Transmission electron micrograph of an intraislet ductule comprised of four cells (n, nucleus) around a lumen like structure (asterisk) with relatively featureless
cytoplasm compared to surrounding endocrine cells ﬁlled with secretory granules (right side, panel a). (b) Higher magniﬁcation of upper left panel in (a). Arrow shows
cilia. þþ Denotes –>þþDenotes a tight junction (desmosome). Arrowhead shows rare electron dense endocrine granules with an outer membrane surrounding a core of
heterogeneous density. (c) Higher magniﬁcation of upper right box in (a) with arrow showing small lumen with microvilli and cilia. (d) Enlarged view of lower right box in
(a) showing two endocrine granules (arrowheads) Scale bar: (a) 1600 nm; (b) 173 nm; (c) and (d) 260 nm. (B) Electron micrograph showing two cells with clear cytoplasm
surrounded by normal granule laden b cells. (b) Enlargement of the upper left square shows two centrioles (arrows); (c) Upper right square magniﬁcation: clear cell with
surrounding endocrine cells with a long microvillus (three long arrows). (d)and (e) Enlargement of the lower left and lower right square, respectively. Rare round, electron
dense, endocrine granules of different size are dispersed in the cytoplasm with either coarse (b) and (e) arrow heads) or punctate core (c) and (d), thick arrows). (e) þþ–>
þþindicates a tight junction separating the two clear cells. (f) Nuclear immunogold labeling for EGFP. Scale bar: (A) 175 nm; (B) and (C) 212 nm; and (D) 133 nm.
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apical expression of alkaline phosphatase, suggesting they
switched to the enterocyte lineage (Fig. 8B), consistent with our
ﬁndings in neonatal intestine.
We frequently identiﬁed EGFPþ cells that stained for the
goblet cell marker, Muc2 (Fig. 8C and D). Since up to 15% of
duodenal goblet cells arise from Ngn3 expressing cells in normal
mice (Schonhoff et al., 2004), it was difﬁcult to determine if the
EGFP expressing goblet cells were normal descendants of Ngn3þ
cells or endocrine precursor cells that adopted an alternate goblet
cell fate in response to Notch. We examined the frequency of
goblet cells arising from Ngn3þ cells with and without Notch
activation in the colon, where Ngn3 expressing cells normally
contribute to 1.6% of the goblet cell population (Schonhoff et al.,
2004). In Tamoxifen treated Ngn3-CreERT2;ROSAEYFP mice, we
identiﬁed one Muc2þ EYFPþ cell out of 54 EYFP expressing cells,
a percentage consistent with our previous lineage tracing studies
with Ngn3-Cre mice. In contrast, 58% of EGFP-expressing cells
coexpressed Muc2 in Ngn3-CreERT2;ROSANotch/þ mice after Notch
activation. The substantially increased frequency of goblet cells
arising from Ngn3 expressing cells suggests that they switched to
an alternate goblet cell fate as a result of Notch activation rather
than from the inherent low frequency that normally arise from
Ngn3þ cells. These observations also suggest that the Ngn3þ cells
were already committed to secretory lineage differentiation and
that at this stage, Notch favors goblet cell differentiation in
contrast to the inhibition of this lineage with Notch activation
in multipotential cells (Fre et al., 2005; Stanger et al., 2005).We previously showed that a signiﬁcant fraction of Paneth
cells arose from Ngn3þ precursor cells (Schonhoff et al., 2004;
Wang et al., 2007). Since Paneth cells do not appear until several
weeks after birth, we activated Notch in Ngn3þ cells of adult mice
using the inducible Cre line to circumvent neonatal lethality seen
with the noninducible Ngn3-Cre transgene. We crossed ROSAEYFP
mice with Ngn3-CreERT2mice to determine the relative fraction of
Ngn3þ cells that become lysozyme staining Paneth cells using the
conditional transgene. Nearly 40% of EYFPþ cells in the ileum and
9% in the duodenum were lysozyme stained Paneth cells (Fig. 8E
and G). In contrast, no EGFPþ cells in Ngn3-CreERT2; ROSANotch/þ
mice expressed lysozyme, indicating that Notch activation
strongly selected against Paneth cell differentiation, a major
alternate cell fate of Ngn3þ cells (Fig. 8F and G). Thus at this
stage of differentiation, Notch selects against endocrine and
Paneth cell fates in favor of enterocyte and goblet cell
differentiation.
Effects of notch on maturing enteroendocrine cells.
In order to determine the effects of Notch activation in
maturing enteroendocrine cells expressing NeuroD1, we ﬁrst
analyzed the normal cell fate of NeuroD1þ cells in the intestine
by crossing NeuroD1-Cre mice to either ROSAEYFP or ROSA26 (lacZ)
indicator mice. Nearly all cells arising from NeuroD1-expressing
cells appeared to be endocrine restricted as most EYFPþ cells
stained for chromogranin A (Fig. 9A, arrow, inset). In contrast to
Ngn3-Cre mice, NeuroD1-Cre mice did not label either goblet or
Fig. 7. Early enteroendocrine progenitors adopt enterocyte and goblet cell
fates following Notch activation. (A) Duodenum from a P2 Ngn3-Cre; ROSAEYFP
mouse shows cells immunostained for CGA and EYFP (white arrow). (B) Small
intestine from a P2 Ngn3-Cre; ROSANotch/þ mouse showing occasional EGFPþ cells
that coexpressed CGA (B), red arrow). (C) and (D) Small intestine from a 2-month-
old Ngn3-creERT2; ROSANotch/þ mouse treated with Tamoxifen, stained for EGFP
with CGA (C, inset shows a rare EGFPþCGAþ cell), Ki67 (D, inset shows 4 adjacent
Ki67 , EGFPþ cells). Size bars: (A), 39 mM; (B), 21 mM; (C), 27.6 mM; (D), 40.1 mM.
(For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
Fig. 8. Early enteroendocrine progenitors adopt enterocyte and goblet cell
H.J. Li et al. / Developmental Biology 371 (2012) 156–169 165Paneth cells with b-galactosidase expression when crossed to
ROSA26 mice (Fig. 9B and C). Most chromogranin A expressing
enteroendocrine cells in NeuroD1-Cre; ROSAEYFP mice expressed
EYFP, indicating that they arose from cells that expressed or
continue to express NeuroD. The enteroendocrine cell populations
of NeuroD1-Cre;ROSANotch/þ mice appeared identical to wild type
mice, including expression of secretin and cholecystokinin, two
NeuroD1 dependent hormone genes, suggesting that Notch did
not directly affect NeuroD1 (Fig. 9D and F). Our observations
suggest that in the intestine, once maturing cells express Neu-
roD1, they are committed to the enteroendocrine lineage and are
no longer responsive to Notch.fates following Notch activation. (A) Small intestine from a P2 Ngn3-Cre;
ROSANotch/þ mouse, showing EGFPþ cells expressing lactase (LPH); (B) 2-month-
old Ngn3-CreERT2; ROSANotch/þ mouse, treated with Tamoxifen showing alkaline
phosphatase (AP) expression in EGFPþ cells. Dashed line indicates a goblet cell;
(C) Muc2 stained cells in the small intestine of a 2-day old Ngn3-Cre;ROSANotch/þ
mouse express EGFP as indicated by yellow arrowheads; Muc2þEGFP cells are
shown by white arrowheads. (D) Tamoxifen treated 2-month-old Ngn3-creERT2;
ROSANotch/þ mouse, showing Muc2þEGFPþ cells (yellow arrowheads) in the colon,
inset shows a Muc2þEGFPþ goblet cell. (E) and (F) Small intestinal sections from
2-month-old Tamoxifen induced Ngn3-CreERT2; ROSAEYFP (E) or Ngn3-CreERT2;
ROSANotch/þ (F) mice immunostained for lysozyme and EYFP or EGFP. Yellow
arrowheads in (E) show two EYFP expressing Paneth cells; (F) absence of EGFP
expression in Paneth cells. (G) Fraction of Paneth cells arising from Ngn3þ cells in
both Tamoxifen induced Ngn3-CreERT2; ROSAEYFP and Ngn3-CreERT2; ROSANotch/þ
mice. p-values were determined using a type III one-tailed Student t-test:
*po0.0004; **po0.00011. Size bars: (A)–(B) 8.2 mM; (C)–(D) 16.8 mM; (E)
2.2 mM; (F) 2.0 mM. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)Discussion
Expression of Ngn3 and NeuroD1 represent distinct stages of
endocrine differentiation targeted by notch in the pancreas and
intestine
Speciﬁcation and differentiation of endocrine cells of the
pancreas and the intestine involves the stepwise restriction from
multipotent progenitor cells. This stepwise restriction is con-
trolled by the sequential expression of transcription factors that
direct differentiation of each emerging cell type. In many systems,
the effects of Notch depend on timing of the Notch signal, with
Notch acting reiteratively in a stepwise manner at different
developmental stages to regulate multiple cell fate choices and
outcomes during the course of differentiation. In the nervous
system, Notch regulates the cell fate of neural stem cells between
neural or glial precursors. As these precursors further differenti-
ate, Notch inhibits differentiation of neuronal precursors toneurons as well as regulating differentiation of glial precursors
to astrocytes versus oligodendrocyctes (Grandbarbe et al., 2003).
In the immune system, Notch signaling favors differentiation of
Fig. 9. NeuroD1-expressing cells are restricted to the enteroendocrine lineage. (A)–(C) Lineage tracing of NeuroD1þ cells in the small intestine of (A) NeuroD1-Cre;
ROSAEYFP mouse showing EYFP expression in chromogranin Aþ cells. Inset shows a CGAþ/EYFPþ cell at higher magniﬁcation; and (B)–(C) NeuroD1-Cre; ROSA26 mice. PAS
stained goblet cells (B) and lysozyme stained Paneth cells (C) that did not coexpress b-galactosidase (blue). (D)–(F) Small intestinal expression of (D) CGA, (E) secretin, and
(F) CCK in EGFP-expressing cells in a NeuroD1-cre; ROSANotch/þ mouse. Size bars: (A) 42.6 mM; (B) and (C) 14.4 mM; (D) 7 mM; (E) 4.4 mM; (F) 5 mM. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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generation of B-cell precursors. Notch appears to regulate T cell
precursor subtype segregation at later stages of T cell develop-
ment (Anderson et al., 2001).
Prior Notch gain of function and loss of function studies have
concluded that Notch inhibits endocrine differentiation in both the
pancreas and the intestine. In most cases, conditional Notch
activation was initiated in multipotential cells expressing either
Pdx1 in the pancreas or Villin in the intestine, which give rise to
multiple epithelial lineages in the pancreas and intestine, respec-
tively (Fre et al., 2005; Hald et al., 2003; Murtaugh et al., 2003;
Stanger et al., 2005). Thus the observed inhibition of endocrine cell
fate may have resulted from effects on multipotential progenitor
cells rather than a direct effect on endocrine precursor cells.
Likewise, Notch loss of function studies showed excessive endo-
crine differentiation with widespread disruption of Notch pathway
components in the pancreas (Apelqvist et al., 1999; Jensen et al.,
2000). The effects of loss of Notch function on enteroendocrine cells
are less clear. Hes1 null mice showed increased enteroendocrine cell
differentiation (Jensen et al., 2000). In one study, treatment with a
gamma secretase inhibitor had no apparent affect on endocrine cell
number (van Es et al., 2005), while another showed increased
endocrine differentiation (VanDussen et al., 2012). Most prior
studies used generalized Notch loss of function or examined the
effects of altered Notch activity in multipotential cells. As a result, it
is unclear whether Notch directly regulates endocrine cell fate as
opposed to an indirect effect of Notch on an earlier multipotential
progenitor. More recently, conditional deletion of Presenilins in
Ngn3-expressing cells resulted in their switching to an acinar cell
fate (Cras-Meneur et al., 2009). However, deletion of Presenilins did
not alter the eventual endocrine cell fate of more mature Pax6þ
cells, indicating that the effects of Notch loss of function is
dependent on the developmental stage, as we have shown with
Notch activation.
Activation of notch in pancreatic endocrine precursors induces
nonendocrine cell fates.
The present work indicates that Notch activation in early
endocrine precursor cells limits but does not preclude endocrine
differentiation as was suggested by earlier studies (Fre et al.,
2005; Hald et al., 2003; Murtaugh et al., 2003; Stanger et al.,2005). The identiﬁcation of signiﬁcant numbers of PYY- and
glucagon-expressing endocrine cells in the pancreas when Notch
was activated in Ngn3þ cells with the absence of cells expressing
insulin, somatostatin, PP, and ghrelin may indicate endocrine
differentiation was limited to cells expressing two hormones that
appear at the earliest stages of pancreatic endocrine differentia-
tion at e9.5 and do not contribute to b cells that appear later
(Schonhoff et al., 2005; Upchurch et al., 1994). As a result, Notch
activation may prevent the expansion of endocrine cells that gives
rise to islets as well as b and q cells later in gestation. We believe
that the differences between our study and earlier work suggest-
ing that Notch completely blocked endocrine differentiation in
Ngn3þ cells (Murtaugh et al., 2003) can be explained by our use
of an Ngn3-Cre transgene where Cre expression was driven by a
much larger fragment of the Ngn3 gene with resultant expression
in all Ngn3þ cells. In addition, the transgene used previously to
activate Notch resulted in unexplained lethality at e13.5, at an
early stage of endocrine differentiation that precluded analysis of
the cell fate of Ngn3þ cells (Murtaugh et al., 2003).
In the present study, Notch activation by a large Ngn3-Cre
transgene enabled mice to survive after birth, allowing us to
study the effects of Notch on the cell fate of Ngn3þ cells. The
observed switching of Ngn3þ cells to the duct lineage, is con-
sistent with our previous ﬁnding (Schonhoff et al., 2004), as well
as recent ﬁndings by others (Magenheim et al., 2011), that Ngn3þ
cells give rise to duct cells in the developing pancreas. Several
studies have suggested that the level of Ngn3 expression in
endocrine precursor cells plays an important role in their cell
fate with higher levels of Ngn3 protein favoring endocrine
differentiation and lower levels favoring the duct lineage
(Magenheim et al., 2011; Wang et al., 2010). In the absence of
Ngn3 protein, increased numbers of cells expressing the Ngn3
gene in the fetal pancreas became duct cells, resulting in thick-
ened ducts with reduced branching (Magenheim et al., 2011).
Reduced expression of Ngn3 protein when Notch is active may
have a similar role for Ngn3þ cells switching from an endocrine
to a duct cell fate. Although we previously showed that rare
acinar cells arise from Ngn3-expressing cells by lineage tracing
that in normal adult mice (Schonhoff et al., 2004), we never
observed switching to the acinar lineage with Notch activation.
The effects of Notch on maturing pancreatic endocrine cells
have not been extensively studied. Surprisingly, we observed that
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cient plasticity to respond to Notch to become duct cells at a
relatively late stage of endocrine differentiation. Several ﬁndings
reported here suggest that NeuroD1þ cells in the pancreas are not
directly shunted to the duct lineage in response to Notch as was
proposed for Pax4-expressing cells (Greenwood et al., 2007).
Lineage tracing established that NeuroD1 expressing cells are
endocrine-restricted, never giving rise to duct cells as an alternate
cell fate. In addition, we found that duct cells arising from
NeuroD1þ cells in response to Notch no longer expressed Neu-
roD1. The evidence for direct shunting of Pax4þ cells to the duct
cells was not conclusive since lineage tracing of Pax4-expressing
cells failed to identify any nonendocrine cell fates as would be
predicted if cells were shunted as suggested.
Multipotential precursor cells have been proposed to reside in
the tips of embryonic pancreatic epithelium that differentiate into
acinar cells or migrate away from the tips to become either duct
or endocrine cells (Zhou et al., 2007). Cell lineage tracing of Hes1
expressing cells suggest that Notch strongly selects against acinar
differentiation in both embryonic tips as well as in the adult
pancreas (Kopinke et al., 2012; Kopinke et al., 2011). A number of
studies have since proposed that the trunks of the fetal pancreatic
ducts contain a bipotential progenitor cell that may give rise to
the duct or endocrine cell lineage (Kopinke et al., 2012; Kopinke
et al., 2011; Magenheim et al., 2011). The most direct evidence for
the existence of a bipotential progenitor, has been described
recently, indicating that Ngn3þ cells give rise to endocrine or
duct cells and have lost the competence to become acinar cells at
an early stage of pancreagenesis (Beucher et al., 2012). The
primitive cell we identiﬁed with limited ultrastructural features
of both the duct and endocrine cells with Notch activation in
NeuroD1þ cells (Fig. 6), could be related to such a bipotential cell.
We speculate that this novel cell may arise from NeuroD1þ cells
by reverting to an immature bipotential cell (endocrine, duct
restricted) since NeuroD1þ cells never directly give rise to duct
cells unlike Ngn3þ cells.
The effects of notch on intestinal cell fate depend on the timing of the
notch signal
As was the case in the pancreas, the effects of Notch activation
in early enteroendocrine precursors limits but does not comple-
tely block endocrine differentiation in contrast to the complete
absence of enteroendocrine cells with activation of Notch in
villin-expressing cells (Fre et al., 2005). Villin is expressed in all
intestinal lineages as well as their multipotential precursors. The
absence of enteroendocrine cells is likely the result of Notch
activation prior to the initiation of endocrine differentiation
rather than a direct effect on enteroendocrine precursors.
A recent study showed that expression of the Notch ligand Dll1
in intestinal secretory cell lineages was coordinated with their
exit from the cell cycle. Conditional deletion of Dll1 in multi-
potential cells of the intestine resulted in increased numbers of
goblet and enteroendocrine cells, suggesting that lateral inhibi-
tion of adjacent cells limited secretory lineage differentiation of
neighboring cells, which continue to divide with expansion of the
absorptive lineage (Stamataki et al., 2011). In the present work,
Notch was speciﬁcally activated in Ngn3þ enteroendocrine pre-
cursors, making direct comparison to the study described above
difﬁcult. While we observed that enteroendocrine precursor cells
switch to an enterocytic cell fate in response to Notch, they do not
appear to reenter the cell cycle, remaining post-mitotic.
Although we previously found that about 15% of goblet cells in
the proximal small intestine arose from Ngn3þ cells (Schonhoff
et al., 2004), our ﬁndings that Notch induced some enteroendo-
crine precursor cells to become goblet cells was unexpected. Anumber of earlier studies showed that increased Notch activity
increased Hes1 expression resulting in a profound reduction of
goblet cell numbers (Fre et al., 2005; Stanger et al., 2005) whereas
inhibition of Notch signaling resulted in a signiﬁcant expansion of
this lineage (Pellegrinet et al., 2011; Stamataki et al., 2011; van Es
et al., 2005; VanDussen et al., 2012). Another study reported a
modest (40%) increase in goblet cells with conditional activation
in Notch in multipotential cells and suggested that this occurred
only in postmitotic cells (Zecchini et al., 2005). The unexpected
switching to the goblet lineage with over a 30-fold increase in
colonic goblet cells may result from Notch activation at a later
stage of differentiation than prior studies which targeted multiple
epithelial populations in the intestine. Since most Ngn3þ cells are
post mitotic, our results may reﬂect the effects of Notch on
nondividing cells (Bjerknes and Cheng, 2006; Stamataki et al.,
2011).
We previously showed by lineage tracing that up to 45% of
Paneth cells in the proximal small intestine arise from Ngn3-
expressing cells (Schonhoff et al., 2004). Surprisingly, Notch
appears to completely inhibit differentiation of those Paneth cells
that arise from Ngn3þ cells. The role of Notch in Paneth cell
differentiation has received relatively little attention, which may
be in part due to the failure of mice to survive to the age of
4 weeks after birth when Paneth cells ﬁrst appear when Notch
pathway is perturbed in multipotential cells. A potential role for
Notch in Paneth cell differentiation was ﬁrst suggested from
increased numbers of ‘‘intermediate cells’’ seen in mice with
deletion of the tumor suppressor gene, Lkb1, from the intestine
(Shorning et al., 2009). More recently, disruption of the Notch
pathway by conditional deletion of RBPJk in the intestine resulted
in increased numbers of Paneth cells, consistent with our obser-
vations that Notch inhibits Paneth cell differentiation (Kim and
Shivdasani, 2011).
In contrast to the pancreas, Notch activation in maturing
enteroendocrine cells expressing NeuroD1 had no effect on
intestinal differentiation, further indicating that timing and con-
text are the major determinants of the response to Notch. Despite
the much higher turnover rate of the intestinal epithelium
compared to the pancreas, differentiating enteroendocrine cells
do not retain the plasticity to respond to Notch as we observed for
pancreatic endocrine cells.
In conclusion, these studies reveal unanticipated and pre-
viously uncharacterized differences in the response of early and
late endocrine precursor cells in the pancreas and the intestine to
active Notch signaling. Notch activation in early endocrine pre-
cursor cells in the pancreas and intestine limits endocrine
differentiation with many cells switching to alternate non-
endocrine cell fates including duct cells in the pancreas as well
as to enterocytes and goblet cells in the intestine. Surprisingly,
some late pancreatic precursor cells retain to capacity to change
their cell fate in response to Notch that may involve a novel
mechanism of reversion to an immature bipotential cell, whereas
maturing enteroendocrine cells have lost the competence to
respond to Notch.Acknowledgements
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